Skip to content

All SAP systems will be unavailable on Saturday 10th December 2022 from 0800-1800 UK Time.

If you can’t place an order, please contact Customer Services to complete your order.

UK/ROW +44 (0) 1223 326050 | US 1 800 872 7423 or 1 212 337 5000 | Australia/New Zealand 61 3 86711400 or 1800 005 210, New Zealand 0800 023 520

Register Sign in Wishlist
Confronting Drug Policy

Confronting Drug Policy
Illicit Drugs in a Free Society

Out of Print

Samuel L. Milbank, Daniel M. Fox, Ronald Bayer, Denise B. Kandel, Avram Goldstein, Harold Kalant, William Kornblum, Charles Winick, Harry G. Levine, Craig Reinarman, Gerald M. Oppenheimer, Mark H. Moore, Laurence O. Gostin, Patricia A. King, Robert J. Levine, Kenneth E. Warner
View all contributors
  • Date Published: December 1993
  • availability: Unavailable - out of print September 1997
  • format: Paperback
  • isbn: 9780521446624

Out of Print

Unavailable - out of print September 1997
Unavailable Add to wishlist

Other available formats:

Looking for an inspection copy?

This title is not currently available on inspection

Product filter button
About the Authors
  • As the financial and social costs of the war on drugs become increasingly clear, there has been renewed debate about drug control in American society. Why, for instance, do the current policies lump less dangerous drugs with more dangerous ones in making possession of any illegal drug a criminal offense? And why does the United States government spend more on law enforcement to repress drug sales than on treatment for individuals who are addicted to drugs? One alternative to the current prohibitionist policies is decriminalisation - a proposal that has drawn both supporters and critics from across the political spectrum. In its most radical form, decriminalisation would entail legalising all drugs; but it could also mean ending the prosecution of small-scale offenses, or treating drug use as a medical, as opposed to a criminal, problem. In this volume, leading analysts of drug use and drug policy evaluate the prospects for decriminalisation as well as its potential impact on public policy, law, medicine, society, and the individual.

    • An important contribution to the debate about how to control the drug problem
    • Sets out clearly the case for and against drug decriminalisation
    • Ronald Bayer is a well-respected name in the field, well-known for his books on health issues and AIDS
    Read more

    Customer reviews

    Not yet reviewed

    Be the first to review

    Review was not posted due to profanity


    , create a review

    (If you're not , sign out)

    Please enter the right captcha value
    Please enter a star rating.
    Your review must be a minimum of 12 words.

    How do you rate this item?


    Product details

    • Date Published: December 1993
    • format: Paperback
    • isbn: 9780521446624
    • length: 379 pages
    • dimensions: 227 x 151 x 18 mm
    • weight: 0.501kg
    • contains: 2 b/w illus. 33 tables
    • availability: Unavailable - out of print September 1997
  • Table of Contents

    Foreword Samuel L. Milbank and Daniel M. Fox
    1. Introduction: the great drug policy debate - what means this thing called decriminalisation? Ronald Bayer
    2. The social demography of drug use Denise B. Kandel
    3. Drug policy: striking the right balance Avram Goldstein and Harold Kalant
    4. Drug legalization and the minority poor William Kornblum
    5. Social behaviour, public policy, and non-harmful drug use Charles Winick
    6. From prohibition to regulation: lessons from alcohol policy for drug policy Harry G. Levine and Craig Reinarman
    7. To build a bridge: the use of foreign models by domestic critics of U.S. drug policy Gerald M. Oppenheimer
    8. Drugs, the criminal law, and the administration of justice Mark H. Moore
    9. Compulsory treatment for drug-dependant persons: justifications for a public health approach to drug dependency Lawrence O. Gostin
    10. Helping women helping children: drug policy and future generations Patricia A. King
    11. Medicalization of psychoactive substance use and the doctor-patient relationship Robert J. Levine
    12. Legalizing drugs: lessons from (and about) economics Kenneth E. Warner
    Notes on contributors

  • Editors

    Ronald Bayer, Columbia University, New York

    Gerald M. Oppenheimer, Brooklyn College, City University of New York


    Samuel L. Milbank, Daniel M. Fox, Ronald Bayer, Denise B. Kandel, Avram Goldstein, Harold Kalant, William Kornblum, Charles Winick, Harry G. Levine, Craig Reinarman, Gerald M. Oppenheimer, Mark H. Moore, Laurence O. Gostin, Patricia A. King, Robert J. Levine, Kenneth E. Warner

Sorry, this resource is locked

Please register or sign in to request access. If you are having problems accessing these resources please email

Register Sign in
Please note that this file is password protected. You will be asked to input your password on the next screen.

» Proceed

You are now leaving the Cambridge University Press website. Your eBook purchase and download will be completed by our partner Please see the permission section of the catalogue page for details of the print & copy limits on our eBooks.

Continue ×

Continue ×

Continue ×
warning icon

Turn stock notifications on?

You must be signed in to your Cambridge account to turn product stock notifications on or off.

Sign in Create a Cambridge account arrow icon

Find content that relates to you

Join us online

This site uses cookies to improve your experience. Read more Close

Are you sure you want to delete your account?

This cannot be undone.


Thank you for your feedback which will help us improve our service.

If you requested a response, we will make sure to get back to you shortly.

Please fill in the required fields in your feedback submission.